公司資料
OpGen 股價、新聞與催化劑
- 股票代碼:
- OPGN
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股價為何變動
Current closing-price context is not available for OPGN.
公司概覽
業務概覽
OpGen was a molecular diagnostics company focused on infectious disease and rapid genomic testing before becoming a historical ticker. Its business centered on helping clinicians identify pathogens and resistance faster.
所在地與產業分類
OpGen was headquartered in the United States and traded on NASDAQ. It sat in diagnostics and molecular testing.
商業模式特徵
The company depended on test adoption, commercialization, and hospital workflow integration. Investors historically watched revenue, reimbursement, and operational execution.
生技產業定位
OpGen belongs to the historical diagnostics infrastructure category. It is not a drug stock, but it supported the testing ecosystem that informs patient care.
未來催化劑
- OpGen is a legacy / closeout story, so the catalysts are any final strategic or asset-resolution update rather than a live diagnostic milestone. The market is focused on residual value.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。